Enanta Pharmaceuticals (ENTA) Capital Leases (2015 - 2019)
Enanta Pharmaceuticals' (ENTA) quarterly Capital Leases came in at $200000.0 in Q3 2019, down 31.74% YoY from $293000.0 in Q3 2018, and down 10.71% on a QoQ basis from $224000.0 in Q2 2019.
Enanta Pharmaceuticals (ENTA) Capital Leases (2015 - 2019) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 5 years of Capital Leases data on file, last reported at $200000.0 in Q3 2019.
- Quarterly Capital Leases fell 31.74% year-over-year to $200000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $200000.0 (down 31.74% YoY) and the FY2019 annual result came in at $200000.0, down 31.74% from the prior year.
- Capital Leases slipped to $200000.0 in Q3 2019, from $224000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $529000.0 in Q3 2015 to a low of $175000.0 in Q2 2015.
- A 5-year average of $364166.7 and a median of $368500.0 in 2017 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2016 — Capital Leases soared 173.14% — and 2019, when it slumped 31.74%.
- Tracing ENTA's Capital Leases over 5 years: stood at $513000.0 in 2015, then declined by 14.23% to $440000.0 in 2016, then dropped by 18.64% to $358000.0 in 2017, then dropped by 24.3% to $271000.0 in 2018, then slipped by 26.2% to $200000.0 in 2019.
- The last three Capital Leases figures came in at $200000.0 (Q3 2019), $224000.0 (Q2 2019), and $249000.0 (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 224,000.00 |
| Mar 31, 2019 | 249,000.00 |
| Dec 31, 2018 | 271,000.00 |
| Sep 30, 2018 | 293,000.00 |
| Jun 30, 2018 | 315,000.00 |
| Mar 31, 2018 | 337,000.00 |
| Dec 31, 2017 | 358,000.00 |
| Sep 30, 2017 | 379,000.00 |
| Jun 30, 2017 | 402,000.00 |
| Mar 31, 2017 | 421,000.00 |
| Dec 31, 2016 | 440,000.00 |
| Sep 30, 2016 | 458,000.00 |
| Jun 30, 2016 | 478,000.00 |
| Mar 31, 2016 | 513,000.00 |
| Dec 31, 2015 | 513,000.00 |
| Sep 30, 2015 | 529,000.00 |
| Jun 30, 2015 | 175,000.00 |